Purchase Order HHSN302201700235P

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on July 31, 2018, with final completion by August 29, 2018. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The purchase order procures sequencing reagents, consumables, or related bioinformatics products from Illumina's core portfolio of DNA and RNA sequencing supplies and software.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $8,182.85 on August 15, 2017, with ultimate completion on September 14, 2017. Place of performance is Bethesda, Maryland. The order procures sequencing reagents, consumables, or related products under firm fixed price terms. No set-aside was applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $16,285.00 on August 15, 2017, with a completion date of December 1, 2017. No set-aside was used. Place of performance is Bethesda, Maryland. The order covers sequencing reagents, consumables, or related bioinformatics supplies, consistent with Illumina's core product line of DNA and RNA sequencing instruments and materials. Pricing is firm fixed price.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $22,572.40 on August 18, 2017, with ultimate completion on September 17, 2017. The order is firm fixed price with no set-aside. Performance takes place in North Bethesda, Maryland. The procurement covers sequencing reagents, consumables, or related biotechnology products consistent with Illumina's core offerings to NIH institutes.</p>

<p>The National Human Genome Research Institute awarded a firm fixed-price purchase order to Illumina, Inc., valued at $7,560.42, on August 18, 2017. Performance is located in North Bethesda, Maryland, with an ultimate completion date of September 17, 2017. The order procures supplies—consistent with Illumina's standard provision of genetic sequencing and genomic analysis technologies, reagents, or consumables to the federal research community.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $19,792.44 on August 15, 2018, for DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software. Performance is at North Bethesda, Maryland, with an ultimate completion date of September 14, 2018. The order carries firm fixed price terms and no set-aside designation.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $21,912.66 on August 2, 2017, with performance completion by September 1, 2017. Work is performed in Bethesda, Maryland. The order procures sequencing reagents, consumables, or related bioinformatics materials—Illumina's core product offerings to federal research agencies. No set-aside category applies.</p>

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $13,029.68 delivery order to Illumina, Inc. on September 12, 2017, for genetic sequencing and genomic analysis equipment and supplies.</p> <p>Place of performance is North Bethesda, Maryland. The order has a firm fixed-price structure and an ultimate completion date of October 11, 2017. No set-aside was used.</p>